Improved fill-and-finish processes reduce the total cost of ownership
Download the whitepaper and discover how enhanced fill-and-finish processes can lower the total cost of ownership!
Pharmaceutical companies are constantly evaluating the efficiency of their filling lines to achieve higher yields with fewer resources, ensuring high-quality standards and maintaining flexibility in the fill-and-finish process. There are three main challenges impacting drug manufacturing and filling operations:
1) Reducing value chain complexity: Outsourcing production steps allows pharma companies to concentrate on their core business.
2) Ensuring patient safety: Identifying and mitigating risks along the value chain is crucial.
3) Maximizing patent lifetimes: Accelerating time to market is essential.
Lower cost, better quality, and higher flexibility are contradictory goals. Read this whitepaper to learn more!
The article was initially published in European Pharmaceutical Manufacturing in 2023.
Pharmaceutical companies are constantly evaluating the efficiency of their filling lines to achieve higher yields with fewer resources, ensuring high-quality standards and maintaining flexibility in the fill-and-finish process. There are three main challenges impacting drug manufacturing and filling operations:
1) Reducing value chain complexity: Outsourcing production steps allows pharma companies to concentrate on their core business.
2) Ensuring patient safety: Identifying and mitigating risks along the value chain is crucial.
3) Maximizing patent lifetimes: Accelerating time to market is essential.
Lower cost, better quality, and higher flexibility are contradictory goals. Read this whitepaper to learn more!
The article was initially published in European Pharmaceutical Manufacturing in 2023.
